Inventiva reports €69.5 million loss ahead of pivotal readout
Inventiva ($IVA) reported a first-half net loss of €69.5 million, compared with €175.9 million a year earlier. Research and development spending increased to €46.2 million, while general and administrative expenses rose to €22.2 million as the company prepared for potential commercialization of lanifibranor. Cash and cash equivalents were €166.1 million, supplemented by €67.8 million in short-term deposits at the half-year end. The company maintained its cash-runway guidance and expects topline
0